They provide labeled carbon substrates whose fate can be followed as they move through downstream metabolic pathways. In cancer imaging, pyruvate serves as an example, and its conversion into lactate supplies a measurable metabolic signal. Because these changes are captured in real time, the approach can assess metabolic activity rather than relying only on tissue structure.
The pyruvate-to-lactate conversion links a detected downstream metabolite to how tissue processes a carbon-containing nutrient. Comparing this signal across regions can reveal metabolic differences between healthy and malignant tissue. The resulting information complements anatomical imaging by showing functional variation that may not be apparent from structural features alone.
Magnetic resonance detection records metabolic conversions while preserving spatial information about where they occur. This combination allows researchers to relate a biochemical signal, such as downstream lactate production, to particular tissue regions. Spatially resolved measurements therefore support comparisons within a tumor and between malignant and healthy areas, rather than providing only a whole-tissue metabolic average.
The process begins by introducing a hyperpolarized 13C-labeled compound, such as pyruvate, into the body. Magnetic resonance imaging then detects the labeled material and its rapid conversion into downstream metabolites. The resulting measurements are interpreted as spatially localized metabolic information, allowing investigators to examine how different tissues process the introduced carbon source.
Researchers can use the method when anatomical images alone do not show enough about tumor function. Measurements of altered metabolism may help distinguish malignant from healthy tissue and provide a way to examine changes during treatment. Tracking these metabolic differences can therefore support tumor characterization and assessment of treatment responses through functional information.
The technique connects a treatment strategy with measurable changes in tumor metabolism. By showing how cancerous and healthy tissues process labeled nutrients, it can provide functional evidence for evaluating metabolic differences and treatment effects. This information supports research aimed at developing therapies that target cancer metabolism and at determining whether metabolic activity changes during intervention.